Ribosome subunit attrition and activation of the p53–MDM4 axis dominate the response of MLL-rearranged cancer cells to WDR5 WIN site inhibition

The chromatin-associated protein WDR5 is a promising target for cancer drug discovery, with most efforts blocking an arginine-binding cavity on the protein called the “WIN” site that tethers WDR5 to chromatin. WIN site inhibitors (WINi) are active against multiple cancer cell types in vitro, the mos...

Descripción completa

Detalles Bibliográficos
Autores principales: Howard, Gregory C., Wang, Jing, Rose, Kristie Lindsey, Patel, Purvi, Tsui, Tina, Florian, Andrea C., Lorey, Shelly L., Grieb, Brian C., Smith, Brianna N., Slota, Macey J., Reynolds, Elizabeth M., Goswami, Soumita, Savona, Michael R., Lee, Taekyu, Fesik, Stephen W., Liu, Qi, Tansey, William P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402127/
https://www.ncbi.nlm.nih.gov/pubmed/37546802
http://dx.doi.org/10.1101/2023.07.26.550648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402127/
https://www.ncbi.nlm.nih.gov/pubmed/37546802
http://dx.doi.org/10.1101/2023.07.26.550648

Ejemplares similares